S31 Ovarian Development

Program: Symposia
Basic Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 162 (BCEC)
Raymond J Rodgers, PhD, University of Adelaide, Adelaide, Australia

Nothing to Disclose: RJR
8:15 AM
Blanche Capel, PhD, Cell Biology, Duke University, Durham, NC
Nothing to Disclose: BC
8:45 AM
Seppo J Vainio, PhD, Faculty of Biochemistry and Molecular Medicine, Oulu University, Oulu, Finland
Nothing to Disclose: SJV
9:15 AM
Rebecca Louise Robker, PhD, Robinson Research Institute, University of Adelaide, Adelaide SA, Australia
Nothing to Disclose: RLR
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire